Smoking impairs the effect of neoadjuvant FOLFIRINOX on postresection survival in pancreatic cancer

Smoking plays an important role in carcinogenesis, including pancreatic ductal adenocarcinoma (PDAC). However, little is known about the association between smoking status and prognosis in resected PDAC. All patients who underwent resection for PDAC were identified from two prospective institutional...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of cancer (1990) 2023-11, Vol.193, p.113293-113293, Article 113293
Hauptverfasser:	Leonhardt, Carl-Stephan, Pils, Dietmar, Qadan, Motaz, Gustorff, Charlotte, Sahora, Klaus, Klaiber, Ulla, Warshaw, Andrew L., Prager, Gerald, Ferrone, Cristina R., Lillemoe, Keith D., Schindl, Martin, Strobel, Oliver, Castillo, Carlos Fernández-del, Hank, Thomas
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - adverse effects Carcinoma, Pancreatic Ductal - drug therapy Carcinoma, Pancreatic Ductal - surgery Cigarette Fluorouracil - therapeutic use FOLFIRINOX Humans NAT Neoadjuvant therapy Neoadjuvant Therapy - adverse effects Pancreatic cancer Pancreatic Neoplasms Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - surgery Pancreatic surgery PDAC Prognostic factors Prospective Studies Retrospective Studies Smoking Smoking - adverse effects Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!